These data are consistent with previous reports showing that reduced insulin signaling leads to hypoglycemia and decreased accumulation of fat [60] and point to a conserved role for Trbl in blocking insulin signaling to reduce growth and increase catabolic pathway activity. The gene discussed is INS; the disease is Hypoglycemia.